Extracorporeal Membrane Oxygenation Machine Market
Market Insights on Extracorporeal Membrane Oxygenation Machine covering sales outlook, demand forecast & up-to-date key trends
Extracorporeal Membrane Oxygenation Machinent Market By Product, Service Type, Component, Modality, Patient Type & Region - Forecast 2022 - 2032
Extracorporeal Membrane Oxygenation Machine Market Outlook (2022-2032)
[311 Pages Report] The global extracorporeal membrane oxygenation machine market size stood at US$ 531 Mn in 2021 and is expected to grow at a steady CAGR of 5% during the forecast period from 2022 to 2032, reaching a valuation of US$ 908 Bn by the end of 2032.
Rising adoption of extracorporeal membrane oxygenation machines is attributed to the increasing prevalence of chronic diseases and rapid growth in organ transplantation procedures worldwide.
|
Data Points |
Market Insights |
|
Extracorporeal Membrane Oxygenation Machine Market Value 2022 |
USD 531 Mn |
|
Extracorporeal Membrane Oxygenation Machine Market Value 2026 |
USD 673 Mn |
|
Extracorporeal Membrane Oxygenation Machine Market Projected Value 2032 |
USD 908 Mn |
|
Extracorporeal Membrane Oxygenation Machine Market Forecast CAGR (2022-2032) |
|
|
Key Players |
Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed. |
Rising complications during surgical procedures like heart transplants has prompted medical professionals to adopt innovative devices like extracorporeal membrane oxygenation machines in healthcare settings.
Extracorporeal membrane oxygenation machines are advanced medical devices used to provide prolonged cardiac and respiratory support to persons whose heart and lungs are unable to function properly. They have become ideal tools used in the care of adults and children with severe cardiac and pulmonary dysfunction.
These machines are mostly used when all the other medical options prove ineffective for patients whose lungs can’t provide enough oxygen to their body or can’t get rid of carbon dioxide. ECMO machines can also be used for patients undergoing heart or lung transplants.
Increasing prevalence of chronic diseases coupled with rapid surge in heart and lung transplants is emerging as a key factor in boosting the sales of extracorporeal membrane oxygenation machines and the trend is likely to escalate during the forecast period.
Leading extracorporeal oxygenation machine manufacturers are continuously innovating to develop advanced products that can help end users to effectively treat patients with heart or lung failures. For instance, in 2020, INTEGRIS Health and EMSA unveiled a one-of-a-kind specialty care ECMO ambulance.
Additionally, advancement in lung pulmonary airway disease treatment, presence of favorable reimbursement policies, and expansion of healthcare industry across developing regions of Asia and Africa will further expand the extracorporeal membrane oxygenation machine market size during the forthcoming years.
Let us know your requirement to get
100% FREE customization
2015-2021 Market Demand Outlook For Extracorporeal Membrane Oxygenation Machine Market Compared To 2022-2032 Forecast
The global demand for extracorporeal membrane oxygenation machines is anticipated to grow at a moderate CAGR of 5% during the forecast period between 2022 and 2032. Growth in the market is driven by rising prevalence of cardiovascular and respiratory diseases, growing adoption of ECMO in lung and heart transplantation procedures, increase in the number of ECMO centers, and advancements in extracorporeal membrane oxygenation machines.
Extracorporeal membrane oxygenation has become one of the most widely used techniques for providing effective circulation and respiratory support in critically ill patients. It has emerged as an ideal alternative to cardiopulmonary bypass (CPB) used during organ transplantation procedures.
Increasing prevalence of chronic diseases such as COPD and along with the rise in the number of heart and lung transplantation procedures being performed is providing a major impetus to the extracorporeal membrane oxygenation machine market growth.
As per the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) was the third leading cause of death worldwide in 2019, causing around 3.23 million deaths. This rise in mortality rate of respiratory and cardiovascular diseases will continue to expand extracorporeal membrane oxygenation machine market size during the forthcoming years.
Similarly, growing geriatric population and favorable government laws, investments, and initiatives are creating growth avenues within the global extracorporeal membrane oxygenation machine market.
ECMO machines offer various benefits such as higher speed and short processing times which is fueling their adoption across various end use verticals such as intensive care units, operating rooms, cardiac catheterization labs, and emergency departments.
The outbreak of COVID-19 created new opportunities for ECMO equipment manufacturers during the last few years. They become essential tools for improving the survival chances of severe COVID-19 patients.
What are the Challenges Faced by the Extracorporeal Membrane Oxygenation Machine Market?
There is no doubt that sales of extracorporeal membrane oxygenation machines are gathering huge across end use verticals. However, there are various factors that are slowing down the growth of extracorporeal membrane oxygenation machine market.
Some of these factors are the increasing extracorporeal membrane oxygenation machine prices due to frequent advancements, scarcity of qualified professionals, and low availability of these devices in some regions.
Country-Wise Insights
What Makes the U.S. Most Dominant Market for Extracorporeal Membrane Oxygenation Machines?
“Rise in Organ Transplantation Procedures Augmenting Demand for ECMO Machines in the U.S.”
As per FMI, the U.S. will continue to remain the most lucrative market for extracorporeal membrane oxygenation machines during the forecast period, owing to the rapidly developing healthcare sector, rising adoption of advanced technologies, surge in the number of lung cancer surgeries performed, heavy presence of leading medical device manufacturers, favorable government support, and increasing prevalence of chronic diseases.
The United States has one of the most developed and sophisticated healthcare industries in the world. Both government and non-government organizations are putting efforts to make advanced medical technologies available to healthcare professionals across the country. This will continue to generate lucrative opportunities for ECMO machine manufacturers during the forecast period.
Similarly, a sharp rise in the number of organ transplants is fueling the adoption of ECMO machines in the country. According to the Health Resource and Service Administration (HRSA), the number of heart transplants performed in adults alone rose to 3715 in 2020.
Why is Demand for Extracorporeal Membrane Oxygenation Machines Rising Across Japan?
“Rise in Organ Transplantation Procedures Creating Demand for ECMO Machines in Japan”
In recent years, demand for ECMO machines has risen at a significant pace across Japan and this trend is likely to continue during the forecast period, owing to the rising geriatric population, increasing healthcare spending, surge in chronic disease cases, booming organ transplant market, favorable government initiatives, and availability of advanced medical technologies.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystCategory-Wise Insights
Which Product is Top Selling Product in the Global Extracorporeal Membrane Oxygenation Machine Market?
“Demand for ECMO Machines to Remain High Throughout the Forecast Period”
By product, the global extracorporeal membrane oxygenation machine market has been segmented into ECMO machines and software. Among these, ECMO machines segment dominated the extracorporeal membrane oxygenation machine market in 2021 and is forecast to grow at a relatively higher CAGR over the assessment period.
Factors such as the growing popularity of portable ECMO devices, booming healthcare industry, and expansion of portable medical devices market are favoring the growth of this segment.
FMI’s latest extracorporeal membrane oxygenation machine market forecast indicates that demand for portable ECMO machines will rise at a substantial pace amid rising adoption of homecare medical devices across developed and developing regions.
Which Service Type Leads the Global Extracorporeal Membrane Oxygenation Machine Market?
“Application Segment to Account for Majority of Revenue Share”
Based on services type, extracorporeal membrane oxygenation machine market is segmented into application, middleware, and infrastructure. Among these, the application segment leads the market growth, accounting for the bulk of the revenue share generated in the market. Rising frequency of target diseases, increasing sales of ECMO machines, and technological improvements in ECMO machines contribute to the growth of this segment.
Which Component Contributes the Most to the Growth of Extracorporeal Membrane Oxygenation Machine Market?
“Sales of Controllers to Continue Rising in the Extracorporeal Membrane Oxygenation Machine Market”
As per FMI, the controllers segment is expected to dominate the extracorporeal membrane oxygenation machine market during the projected period. Rising adoption of controllers by end-users is a major factor triggering the growth of this segment.
By Modality Which Segment Holds the Largest Share in Extracorporeal Membrane Oxygenation Machine Market?
“Arterio-Venous Remains the Most Preferred Modality Type”
Latest extracorporeal membrane oxygenation machine market trends reveal that the arterio-venous segment will continue to lead the global extracorporeal membrane oxygenation machine market during the forecast period, owing to the various benefits such as highly effective nature and better medical evaluation associated with this technology.
Competitive Landscape
Leading extracorporeal membrane oxygenation machine manufacturers are constantly focusing on new product launches and approvals for expanding their product portfolios. Besides this, they have adopted growth strategies such as partnerships, acquisitions, mergers, joint ventures, and collaborations to gain a competitive edge in the global extracorporeal membrane oxygenation machine market.
For instance,
- In 2020, the U.S. Food and Drug Administration (FDA) approved Novalung extracorporeal membrane oxygenation (ECMO) machine to treat acute respiratory or cardiopulmonary failure.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Extracorporeal Membrane Oxygenation Machine Market Report Scope
FMI’s latest market survey uncovers key investment pockets within the extracorporeal membrane oxygenation machine market. It analyses how key extracorporeal membrane oxygenation machine manufacturers are innovating to meet end user demands.
The study provides inclusive details about extracorporeal membrane oxygenation machine ecosystem and highlights key market governing factors such as growth drivers, restraints, and emerging opportunities. Besides this, it discusses in detail the latest extracorporeal membrane oxygenation machine market trends.
FMI also offers exhaustive research into factors pushing demand for extracorporeal membrane oxygenation machines across developed and developing regions. It attempts to explore the growth potential of regions with a high patient pool and explain how advancements in medical device technologies are affecting the extracorporeal membrane oxygenation machine sales.
Want to get a comprehensive assessment of extracorporeal membrane oxygenation machine market and much more? Keep in touch with “Future Market Insights”, one of the leading research companies of the world.
The Extracorporeal Membrane Oxygenation Machine Market analysis includes:
- A 10-year realistic extracorporeal membrane oxygenation machine sales forecast across multiple verticals
- Detailed analysis of regional pockets along with degree of market penetration
- Impact of evolving respiratory devices on extracorporeal membrane oxygenation machine market forecast.
- Exclusive recommendations on how to penetrate attractive ECMO machine markets of Asia, Africa, and others.
- Insights into emerging end user demands and current extracorporeal membrane oxygenation machine market trends.
- Top extracorporeal membrane oxygenation machine manufacturers and their growth strategies
- Market dynamics including drivers, restraints, and emerging opportunities
- Compelling insights into various products and services types in extracorporeal membrane oxygenation machines market.
- Pricing analysis
- The winning imperatives in extracorporeal membrane oxygenation machine market.
|
Attribute |
Details |
|
Forecast Period |
2022-2032 |
|
Historic Data Available for |
2015-2021 |
|
Market Analysis |
USD Million for Value |
|
Report Coverage |
Market forecast, company share analysis, competition intelligence, DROT analysis, market dynamics and challenges, and strategic growth initiatives |
|
Key Segments Covered |
By product, By Service Type, By Component, By Modality, By Patient Type, By Region |
|
Key regions covered |
North America
Latin America
Western Europe
Eastern Europe
South Asia Pacific
Middle East & Africa
Rest of the World
|
|
Patient Type |
|
|
Key companies profiled |
Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Origin Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents Corporation (Australia), and Abiomed. |
|
Customization & pricing |
Available upon request |
Key Segments
By Product:
- ECMO Machines
- Portable Devices
- Static Devices
- Software
By Service Type:
- Application
- Middleware
- Infrastructure
By Component:
- Pumps
- Oxygenators
- Controllers
- Cannula
- Accessories
By Modality:
- Veno-Venous
- Veno-Arterials
- Arterio-Venous
By Patient Type:
- Neonates
- Pediatrics
- Adults
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
The global extracorporeal membrane oxygenation market was estimated to be worth US$ 531 Mn in 2021.
As per FMI, the global extracorporeal membrane oxygenation machine market is expected to grow at 5% CAGR during the forecast period, totaling US$ 908 Mn by 2032.
Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA (Germany), Getinge Group (Sweden), Microport (China), Terumo Cardiovascular Systems Corporation, Livanova plc (U.K.), Nipro Corporation (Japan) are some of the leading companies operating in the extracorporeal oxygenation machine market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Component
8.1. Introduction / Key Findings
8.2. Historical Market Value (US$ Mn) and Analysis By Component, 2015-2021
8.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Component, 2022-2032
8.3.1. Pumps
8.3.2. Oxygenators
8.3.3. Controllers
8.3.4. Cannul
8.3.5. Assessories
8.4. Market Attractiveness Analysis By Component
9. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Product
9.1. Introduction / Key Findings
9.2. Historical Market Value (US$ Mn) and Analysis By Product , 2015-2021
9.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Product , 2022-2032
9.3.1. ECMO Machines
9.3.1.1. Portable Devices
9.3.1.2. Static Devices
9.3.2. Software
9.4. Market Attractiveness Analysis By Product
10. Global Market Analysis 2015-2021 and Forecast 2022-2032,By Provider
10.1. Introduction / Key Findings
10.2. Historical Market Value (US$ Mn) and AnalysisBy Provider, 2015-2021
10.3. Current and Future Market Value (US$ Mn) and Analysis and ForecastBy Provider, 2022-2032
10.3.1. Application
10.3.2. Middleware
10.3.3. Infrastructure
10.4. Market Attractiveness AnalysisBy Provider
11. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Modality
11.1. Introduction / Key Findings
11.2. Historical Market Value (US$ Mn) and Analysis By Modality , 2015-2021
11.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Modality , 2022-2032
11.3.1. Veno-Venous
11.3.2. Veno-Arterials
11.3.3. Arterio-Venous
11.4. Market Attractiveness Analysis By Modality
12. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Patient Type
12.1. Introduction / Key Findings
12.2. Historical Market Value (US$ Mn) and Analysis By Patient Type , 2015-2021
12.3. Current and Future Market Value (US$ Mn) and Analysis and Forecast By Patient Type , 2022-2032
12.3.1. Neonates
12.3.2. Pediatrics
12.3.3. Adults
12.4. Market Attractiveness Analysis By Patient Type
13. Global Market Analysis 2015-2021 and Forecast 2022-2032, By Region
13.1. Introduction
13.2. Historical Market Value (US$ Mn) and Analysis By Region, 2015-2021
13.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. Asia Pacific
13.3.5. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.1.3. Rest of North America
14.4.2. By Provider
14.4.3. By Component
14.4.4. By Product
14.4.5. By Modality
14.4.6. By Patient Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Provider
14.5.3. By Component
14.5.4. By Product
14.5.5. By Modality
14.5.6. By Patient Type
15. Latin America Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Mexico
15.4.1.3. Rest of Latin America
15.4.2. By Provider
15.4.3. By Component
15.4.4. By Product
15.4.5. By Modality
15.4.6. By Patient Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Provider
15.5.3. By Component
15.5.4. By Product
15.5.5. By Modality
15.5.6. By Patient Type
16. Europe Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. France
16.4.1.3. U.K.
16.4.1.4. Italy
16.4.1.5. Russia
16.4.1.6. Rest of Europe
16.4.2. By Provider
16.4.3. By Component
16.4.4. By Product
16.4.5. By Modality
16.4.6. By Patient Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Provider
16.5.3. By Component
16.5.4. By Product
16.5.5. By Modality
16.5.6. By Patient Type
17. Asia Pacific Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
17.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. China
17.4.1.2. Japan
17.4.1.3. South Korea
17.4.1.4. Rest of Asia Pacific
17.4.2. By Provider
17.4.3. By Component
17.4.4. By Product
17.4.5. By Modality
17.4.6. By Patient Type
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Provider
17.5.3. By Component
17.5.4. By Product
17.5.5. By Modality
17.5.6. By Patient Type
18. Middle East and Africa Market Analysis 2015-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Value (US$ Mn) and Trend Analysis By Market Taxonomy, 2015-2021
18.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
18.4.1. By Country
18.4.1.1. GCC Countries
18.4.1.2. South Africa
18.4.1.3. Turkey
18.4.1.4. Rest of Middle East and Africa
18.4.2. By Provider
18.4.3. By Component
18.4.4. By Product
18.4.5. By Modality
18.4.6. By Patient Type
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Provider
18.5.3. By Component
18.5.4. By Product
18.5.5. By Modality
18.5.6. By Patient Type
19. Key Countries Market Analysis 2015-2021 and Forecast 2022-2032
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. US Market Analysis
19.2.1. Value Proportion Analysis by Market Taxonomy
19.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.2.2.1. By Provider
19.2.2.2. By Component
19.2.2.3. By Product
19.2.2.4. By Modality
19.2.2.5. By Patient Type
19.3. Canada Market Analysis
19.3.1. Value Proportion Analysis by Market Taxonomy
19.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.3.2.1. By Provider
19.3.2.2. By Component
19.3.2.3. By Product
19.3.2.4. By Modality
19.3.2.5. By Patient Type
19.4. Mexico Market Analysis
19.4.1. Value Proportion Analysis by Market Taxonomy
19.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.4.2.1. By Provider
19.4.2.2. By Component
19.4.2.3. By Product
19.4.2.4. By Modality
19.4.2.5. By Patient Type
19.5. Brazil Market Analysis
19.5.1. Value Proportion Analysis by Market Taxonomy
19.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.5.2.1. By Provider
19.5.2.2. By Component
19.5.2.3. By Product
19.5.2.4. By Modality
19.5.2.5. By Patient Type
19.6. Germany Market Analysis
19.6.1. Value Proportion Analysis by Market Taxonomy
19.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.6.2.1. By Provider
19.6.2.2. By Component
19.6.2.3. By Product
19.6.2.4. By Modality
19.6.2.5. By Patient Type
19.7. France Market Analysis
19.7.1. Value Proportion Analysis by Market Taxonomy
19.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.7.2.1. By Provider
19.7.2.2. By Component
19.7.2.3. By Product
19.7.2.4. By Modality
19.7.2.5. By Patient Type
19.8. Italy Market Analysis
19.8.1. Value Proportion Analysis by Market Taxonomy
19.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.8.2.1. By Provider
19.8.2.2. By Component
19.8.2.3. By Product
19.8.2.4. By Modality
19.8.2.5. By Patient Type
19.9. Russia Market Analysis
19.9.1. Value Proportion Analysis by Market Taxonomy
19.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.9.2.1. By Provider
19.9.2.2. By Component
19.9.2.3. By Product
19.9.2.4. By Modality
19.9.2.5. By Patient Type
19.10. UK Market Analysis
19.10.1. Value Proportion Analysis by Market Taxonomy
19.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.10.2.1. By Provider
19.10.2.2. By Component
19.10.2.3. By Product
19.10.2.4. By Modality
19.10.2.5. By Patient Type
19.11. China Market Analysis
19.11.1. Value Proportion Analysis by Market Taxonomy
19.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.11.2.1. By Provider
19.11.2.2. By Component
19.11.2.3. By Product
19.11.2.4. By Modality
19.11.2.5. By Patient Type
19.12. Japan Market Analysis
19.12.1. Value Proportion Analysis by Market Taxonomy
19.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.12.2.1. By Provider
19.12.2.2. By Component
19.12.2.3. By Product
19.12.2.4. By Modality
19.12.2.5. By Patient Type
19.13. South Korea Market Analysis
19.13.1. Value Proportion Analysis by Market Taxonomy
19.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.13.2.1. By Provider
19.13.2.2. By Component
19.13.2.3. By Product
19.13.2.4. By Modality
19.13.2.5. By Patient Type
19.14. GCC Countries Market Analysis
19.14.1. Value Proportion Analysis by Market Taxonomy
19.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.14.2.1. By Provider
19.14.2.2. By Component
19.14.2.3. By Product
19.14.2.4. By Modality
19.14.2.5. By Patient Type
19.15. South Africa Market Analysis
19.15.1. Value Proportion Analysis by Market Taxonomy
19.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.15.2.1. By Provider
19.15.2.2. By Component
19.15.2.3. By Product
19.15.2.4. By Modality
19.15.2.5. By Patient Type
19.16. Turkey Market Analysis
19.16.1. Value Proportion Analysis by Market Taxonomy
19.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
19.16.2.1. By Provider
19.16.2.2. By Component
19.16.2.3. By Product
19.16.2.4. By Modality
19.16.2.5. By Patient Type
19.16.3. Competition Landscape and Player Concentration in the Country
20. Market Structure Analysis
20.1. Market Analysis by Tier of Companies
20.2. Market Concentration
20.3. Market Share Analysis of Top Players
20.4. Market Presence Analysis
20.4.1. By Regional footprint of Players
20.4.2. Product footprint by Players
21. Competition Analysis
21.1. Competition Dashboard
21.2. Competition Benchmarking
21.3. Competition Deep Dive
21.3.1. FRESENIUS MEDICAL CARE
21.3.1.1. Overview
21.3.1.2. Product Portfolio
21.3.1.3. Sales Footprint
21.3.1.4. Strategy Overview
21.3.2. GETINGE GROUP
21.3.2.1. Overview
21.3.2.2. Product Portfolio
21.3.2.3. Sales Footprint
21.3.2.4. Strategy Overview
21.3.3. MEDTRONIC PLC
21.3.3.1. Overview
21.3.3.2. Product Portfolio
21.3.3.3. Sales Footprint
21.3.3.4. Strategy Overview
21.3.4. MICROPORT
21.3.4.1. Overview
21.3.4.2. Product Portfolio
21.3.4.3. Sales Footprint
21.3.4.4. Strategy Overview
21.3.5. TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
21.3.5.1. Overview
21.3.5.2. Product Portfolio
21.3.5.3. Sales Footprint
21.3.5.4. Strategy Overview
21.3.6. NIPRO CORPORATION
21.3.6.1. Overview
21.3.6.2. Product Portfolio
21.3.6.3. Sales Footprint
21.3.6.4. Strategy Overview
21.3.7. LIVANOVA PLC
21.3.7.1. Overview
21.3.7.2. Product Portfolio
21.3.7.3. Sales Footprint
21.3.7.4. Strategy Overview
21.3.8. EUROSETS S.R.L
21.3.8.1. Overview
21.3.8.2. Product Portfolio
21.3.8.3. Sales Footprint
21.3.8.4. Strategy Overview
21.3.9. ORIGEN BIOMEDICAL, INC
21.3.9.1. Overview
21.3.9.2. Product Portfolio
21.3.9.3. Sales Footprint
21.3.9.4. Strategy Overview
21.3.10. CYTOSORBENTS CORPORATION
21.3.10.1. Overview
21.3.10.2. Product Portfolio
21.3.10.3. Sales Footprint
21.3.10.4. Strategy Overview
22. Assumptions and Acronyms Used
23. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn),By Provider, 2015 – 2021
Table 2: Global Market Value (US$ Mn),By Provider, 2022 – 2032
Table 3: Global Market Value (US$ Mn), By Component, 2015 – 2021
Table 4: Global Market Value (US$ Mn), By Component, 2022 – 2032
Table 5: Global Market Value (US$ Mn), By Product , 2015 – 2021
Table 6: Global Market Value (US$ Mn), By Product , 2022 – 2032
Table 7: Global Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 8: Global Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 9: Global Market Value (US$ Mn), By Modality , 2015 – 2021
Table 10: Global Market Value (US$ Mn), By Modality , 2022 – 2032
Table 11: Global Market, By Region, 2015 – 2021
Table 12: Global Market, By Region, 2022 – 2032
Table 13: North America Market Value (US$ Mn),By Provider, 2015 – 2021
Table 14: North America Market Value (US$ Mn),By Provider, 2022 – 2032
Table 15: North America Market Value (US$ Mn), By Component, 2015 – 2021
Table 16: North America Market Value (US$ Mn), By Component, 2022 – 2032
Table 17: North America Market Value (US$ Mn), By Product , 2015 – 2021
Table 18: North America Market Value (US$ Mn), By Product , 2022 – 2032
Table 19: North America Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 20: North America Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 21: North America Market Value (US$ Mn), By Modality , 2015 – 2021
Table 22: North America Market Value (US$ Mn), By Modality , 2022 – 2032
Table 23: North America Market, By Country, 2015 – 2021
Table 24: North America Market, By Country, 2022 – 2032
Table 25: Latin America Market Value (US$ Mn),By Provider, 2015 – 2021
Table 26: Latin America Market Value (US$ Mn),By Provider, 2022 – 2032
Table 27: Latin America Market Value (US$ Mn), By Component, 2015 – 2021
Table 28: Latin America Market Value (US$ Mn), By Component, 2022 – 2032
Table 29: Latin America Market Value (US$ Mn), By Product , 2015 – 2021
Table 30: Latin America Market Value (US$ Mn), By Product , 2022 – 2032
Table 31: Latin America Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 32: Latin America Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 33: Latin America Market Value (US$ Mn), By Modality , 2015 – 2021
Table 34: Latin America Market Value (US$ Mn), By Modality , 2022 – 2032
Table 35: Latin America Market, By Country, 2015 – 2021
Table 36: Latin America Market, By Country, 2022 – 2032
Table 37: Europe Market Value (US$ Mn),By Provider, 2015 – 2021
Table 38: Europe Market Value (US$ Mn),By Provider, 2022 – 2032
Table 39: Europe Market Value (US$ Mn), By Component, 2015 – 2021
Table 40: Europe Market Value (US$ Mn), By Component, 2022 – 2032
Table 41: Europe Market Value (US$ Mn), By Product , 2015 – 2021
Table 42: Europe Market Value (US$ Mn), By Product , 2022 – 2032
Table 43: Europe Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 44: Europe Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 45: Europe Market Value (US$ Mn), By Modality , 2015 – 2021
Table 46: Europe Market Value (US$ Mn), By Modality , 2022 – 2032
Table 47: Europe Market, By Country, 2015 – 2021
Table 48: Europe Market, By Country, 2022 – 2032
Table 49: Asia Pacific Market Value (US$ Mn),By Provider, 2015 – 2021
Table 50: Asia Pacific Market Value (US$ Mn),By Provider, 2022 – 2032
Table 51: Asia Pacific Market Value (US$ Mn), By Component, 2015 – 2021
Table 52: Asia Pacific Market Value (US$ Mn), By Component, 2022 – 2032
Table 53: Asia Pacific Market Value (US$ Mn), By Product , 2015 – 2021
Table 54: Asia Pacific Market Value (US$ Mn), By Product , 2022 – 2032
Table 55: Asia Pacific Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 56: Asia Pacific Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 57: Asia Pacific Market Value (US$ Mn), By Modality , 2015 – 2021
Table 58: Asia Pacific Market Value (US$ Mn), By Modality , 2022 – 2032
Table 59: Asia Pacific Market, By Country, 2015 – 2021
Table 60: Asia Pacific Market, By Country, 2022 – 2032
Table 61: MEA Market Value (US$ Mn),By Provider, 2015 – 2021
Table 62: MEA Market Value (US$ Mn),By Provider, 2022 – 2032
Table 63: MEA Market Value (US$ Mn), By Component, 2015 – 2021
Table 64: MEA Market Value (US$ Mn), By Component, 2022 – 2032
Table 65: MEA Market Value (US$ Mn), By Product , 2015 – 2021
Table 66: MEA Market Value (US$ Mn), By Product , 2022 – 2032
Table 67: MEA Market Value (US$ Mn), By Patient Type , 2015 – 2021
Table 68: MEA Market Value (US$ Mn), By Patient Type , 2022 – 2032
Table 69: MEA Market Value (US$ Mn), By Modality , 2015 – 2021
Table 70: MEA Market Value (US$ Mn), By Modality , 2022 – 2032
Table 71: MEA Market, By Country, 2015 – 2021
Table 72: MEA Market, By Country, 2022 – 2032
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 2: Global Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 3: Global Market Share,By Provider, 2022 & 2032
Figure 4: Global Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 5: Global Market Attractiveness Index,By Provider – 2022-2032
Figure 6: Global Market Share, By Component, 2022 & 2032
Figure 7: Global Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 8: Global Market Attractiveness Index, By Component – 2022-2032
Figure 9: Global Market Share, By Patient Type , 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 11: Global Market Attractiveness Index, By Patient Type – 2022-2032
Figure 12: Global Market Share, By Product , 2022 & 2032
Figure 13: Global Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 14: Global Market Attractiveness Index, By Product – 2022-2032
Figure 15: Global Market Share, By Modality , 2022 & 2032
Figure 16: Global Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 17: Global Market Attractiveness Index, By Modality – 2022-2032
Figure 18: Global Market Share, By Region, 2022 & 2032
Figure 19: Global Market Y-o-Y Growth Projections, By Region – 2022-2032
Figure 20: Global Market Attractiveness Index, By Region – 2022-2032
Figure 21: North America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 22: North America Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 23: North America Market Share,By Provider, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 25: North America Market Attractiveness Index,By Provider – 2022-2032
Figure 26: North America Market Share, By Component, 2022 & 2032
Figure 27: North America Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 28: North America Market Attractiveness Index, By Component – 2022-2032
Figure 29: North America Market Share, By Patient Type , 2022 & 2032
Figure 30: North America Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 31: North America Market Attractiveness Index, By Patient Type – 2022-2032
Figure 32: North America Market Share, By Product , 2022 & 2032
Figure 33: North America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 34: North America Market Attractiveness Index, By Product – 2022-2032
Figure 35: North America Market Share, By Modality , 2022 & 2032
Figure 36: North America Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 37: North America Market Attractiveness Index, By Modality – 2022-2032
Figure 38: North America Market Share, By Country, 2022 & 2032
Figure 39: North America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 40: North America Market Attractiveness Index, By Country – 2022-2032
Figure 41: Latin America Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 42: Latin America Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 43: Latin America Market Share,By Provider, 2022 & 2032
Figure 44: Latin America Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 45: Latin America Market Attractiveness Index,By Provider – 2022-2032
Figure 46: Latin America Market Share, By Component, 2022 & 2032
Figure 47: Latin America Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 48: Latin America Market Attractiveness Index, By Component – 2022-2032
Figure 49: Latin America Market Share, By Patient Type , 2022 & 2032
Figure 50: Latin America Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 51: Latin America Market Attractiveness Index, By Patient Type – 2022-2032
Figure 52: Latin America Market Share, By Product , 2022 & 2032
Figure 53: Latin America Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 54: Latin America Market Attractiveness Index, By Product – 2022-2032
Figure 55: Latin America Market Share, By Modality , 2022 & 2032
Figure 56: Latin America Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 57: Latin America Market Attractiveness Index, By Modality – 2022-2032
Figure 58: Latin America Market Share, By Country, 2022 & 2032
Figure 59: Latin America Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 60: Latin America Market Attractiveness Index, By Country – 2022-2032
Figure 61: Europe Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 62: Europe Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 63: Europe Market Share,By Provider, 2022 & 2032
Figure 64: Europe Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 65: Europe Market Attractiveness Index,By Provider – 2022-2032
Figure 66: Europe Market Share, By Component, 2022 & 2032
Figure 67: Europe Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 68: Europe Market Attractiveness Index, By Component – 2022-2032
Figure 69: Europe Market Share, By Patient Type , 2022 & 2032
Figure 70: Europe Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 71: Europe Market Attractiveness Index, By Patient Type – 2022-2032
Figure 72: Europe Market Share, By Product , 2022 & 2032
Figure 73: Europe Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 74: Europe Market Attractiveness Index, By Product – 2022-2032
Figure 75: Europe Market Share, By Modality , 2022 & 2032
Figure 76: Europe Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 77: Europe Market Attractiveness Index, By Modality – 2022-2032
Figure 78: Europe Market Share, By Country, 2022 & 2032
Figure 79: Europe Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 80: Europe Market Attractiveness Index, By Country – 2022-2032
Figure 81: Asia Pacific Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 82: Asia Pacific Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 83: Asia Pacific Market Share,By Provider, 2022 & 2032
Figure 84: Asia Pacific Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 85: Asia Pacific Market Attractiveness Index,By Provider – 2022-2032
Figure 86: Asia Pacific Market Share, By Component, 2022 & 2032
Figure 87: Asia Pacific Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 88: Asia Pacific Market Attractiveness Index, By Component – 2022-2032
Figure 89: Asia Pacific Market Share, By Patient Type , 2022 & 2032
Figure 90: Asia Pacific Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 91: Asia Pacific Market Attractiveness Index, By Patient Type – 2022-2032
Figure 92: Asia Pacific Market Share, By Product , 2022 & 2032
Figure 93: Asia Pacific Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 94: Asia Pacific Market Attractiveness Index, By Product – 2022-2032
Figure 95: Asia Pacific Market Share, By Modality , 2022 & 2032
Figure 96: Asia Pacific Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 97: Asia Pacific Market Attractiveness Index, By Modality – 2022-2032
Figure 98: Asia Pacific Market Share, By Country, 2022 & 2032
Figure 99: Asia Pacific Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 100: Asia Pacific Market Attractiveness Index, By Country – 2022-2032
Figure 101: MEA Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032
Figure 102: MEA Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn
Figure 103: MEA Market Share,By Provider, 2022 & 2032
Figure 104: MEA Market Y-o-Y Growth Projections,By Provider – 2022-2032
Figure 105: MEA Market Attractiveness Index,By Provider – 2022-2032
Figure 106: MEA Market Share, By Component, 2022 & 2032
Figure 107: MEA Market Y-o-Y Growth Projections, By Component – 2022-2032
Figure 108: MEA Market Attractiveness Index, By Component – 2022-2032
Figure 109: MEA Market Share, By Patient Type , 2022 & 2032
Figure 110: MEA Market Y-o-Y Growth Projections, By Patient Type – 2022-2032
Figure 111: MEA Market Attractiveness Index, By Patient Type – 2022-2032
Figure 112: MEA Market Share, By Product , 2022 & 2032
Figure 113: MEA Market Y-o-Y Growth Projections, By Product – 2022-2032
Figure 114: MEA Market Attractiveness Index, By Product – 2022-2032
Figure 115: MEA Market Share, By Modality , 2022 & 2032
Figure 116: MEA Market Y-o-Y Growth Projections, By Modality – 2022-2032
Figure 117: MEA Market Attractiveness Index, By Modality – 2022-2032
Figure 118: MEA Market Share, By Country, 2022 & 2032
Figure 119: MEA Market Y-o-Y Growth Projections, By Country – 2022-2032
Figure 120: MEA Market Attractiveness Index, By Country – 2022-2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
